Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Precision Medicine
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(26)
1 / 2
Personalized
Regulatory Innovation for a More Personalized Era of Medicine
Pharma's Almanac
PAO-06-26-PA-11
Jun 18, 2026
Peptides
The Resurgence of Peptide Drugs in the Age of Precision Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-16
May 15, 2026
FIll-Finish
Designing Flexible Fill-Finish Platforms for Small-Batch Precision Medicines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-26-PA-08
Mar 12, 2026
OSD
Technologies Enabling Personalized and Patient-Specific Oral Solid Dosage Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-25-NI-02
Nov 11, 2025
Precision Medicine
What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?
Pharma's Almanac
PAO-09-25-NI-02
Sep 2, 2025
Bioelectronic
Singing The Body Electric: Exploring Bioelectronic Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-11
Apr 23, 2025
Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29
Apr 15, 2025
Announcement
Caris Life Sciences Strategically Collaborates with Ontada to Advance Oncology Research and the Adoption of Precision Medicine
Caris Life Sciences
PR-01-25-NI-21
Jan 20, 2025
Announcement
Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke
Genomadix
PR-11-24-NI-106
Nov 15, 2024
Precision Medicine
Advancing Personalized Medicines and Precision Therapeutics
Thermo Fisher Scientific
PAO-11-24-RTM-10
Nov 15, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10
Sep 23, 2024
Digital Twin Technology
The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-23-NI-02
Mar 7, 2023
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02
Oct 11, 2022
Precision Medicine
Examining the Potential of Precision/Personalized Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-03
Oct 11, 2022
Precision Diagnostics
Enabling Precision Medicine via Precision Diagnostics
FACible Biodiagnostics
PAO-03-22-R250-13
Mar 19, 2022
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Pharma's Almanac
PAO-12-21-RT-01
Jan 7, 2022
Precision Medicine
Profiling Cancer Genetics to Enable Precision Therapies
Razelle Kurzrock, MD
585859020
Aug 11, 2021
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
Pharma's Almanac
PAO-03-21-NI-01
Mar 16, 2021
Personalized Medicines
Disruptive Technologies in Life Sciences: Personalized Medicines
Elizabeth Abraham, Ph.D.; Shabana Islam, Ph.D.; Ben Josey, Ph.D.; Alejandro Montoya; Hilary Sherman
Corning Life Sciences
PAP-Q4-20-CL-009
Dec 9, 2020
Joint Venture
SEngine Precision Medicine and Atomwise Announce Strategic Joint Venture to Accelerate Novel Drug Discovery
SEngine Precision Medicine
PR-M09-19-NI-031
Sep 12, 2019
1 / 2